CONSTELLATION PHARMCETICLS I - COM (CNST)

CUSIP: 210373106

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
49,301,088
Share change
+1,281,642
Total reported value
$998,847,612
Put/Call ratio
1.5%
Price per share
$20.26
Number of holders
117
Value change
-$5,132,287
Number of buys
69
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 210373106?
CUSIP 210373106 identifies CNST - CONSTELLATION PHARMCETICLS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q3 2020

As of 30 Sep 2020, CONSTELLATION PHARMCETICLS I - COM (CNST) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,301,088 shares. The largest 10 holders included Svennilson Peter, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, VR Adviser, LLC, GREAT POINT PARTNERS LLC, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, Venrock Management V, LLC, and Bain Capital Life Sciences Investors, LLC. This page lists 117 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.